Soluble complement receptor type 1 inhibits complement system activation and improves motor function in acute spinal cord injury

Spinal Cord

Volumn 48, Issue 2, 2010, Pages 105-111

  Li, L M ^a   Li, J B ^a   Zhu, Y ^a   Fan, G Y ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Complement; Myeloperoxidase; Regeneration medicine; Soluble complement receptor type 1; Spinal cord injury

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C9; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CHINA; COMPLEMENT SYSTEM; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; EVALUATION; EXPERIMENTAL ANIMAL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOTOR PERFORMANCE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SPINAL CORD INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIGENS, CD59; COMPLEMENT ACTIVATION; COMPLEMENT C9; MODELS, ANIMAL; MOTOR NEURONS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, COMPLEMENT; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 76649104339     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2009.104     Document Type: Article

References (19)

1. Reynolds DN, Smith SA, Zhang YP, Mengsheng Q, Lahiri DK, Morassutti DJ et al. Vaccinia virus complement control protein reduces inflammation and improves spinal cord integrity following spinal cord injury. Ann NY Acad Sci 2004; 1035: 165-178.
2. Qiao F, Atkinson C, Song H, Pannu R, Singh I, Tomlinson S. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma. Am J Pathol 2006; 169: 1039-1047.
3. Tei R, Kaido T, Nakase H, Sakaki T. Protective effect of C1 esterase inhibitor on acute traumatic spinal cord injury in the rat. Neurol Res 2008; 30: 712-717.
4. Li LM, Zhu Y, Fan GY. Effects of recombinant sCR1 on the immune inflammatory reaction in acute spinal cord injury tissue of rats. Chin J Traumatol 2005; 8: 49-53.
5. He C, Imai M, Song H, Quigg RJ, Tomlinson S. Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. J Immunol 2005; 174: 5750-5757.
6. Mollnes TE, Jokiranta TS, Truedsson L, Nilsson B, Rodriguez de Cordoba S, Kirschfink M. Complement analysis in the 21st century. Mol Immunol 2007; 44: 3838-3849.
7. Kulkarni AP, Kellaway LA, Kotwal GJ. Herbal complement inhibitors in the treatment of neuroinflammation: future strategy for neuroprotection. Ann NY Acad Sci 2005; 1056: 413-429.
8. Rambach G,Wurzner R, Speth C. Complement: an efficient sword of innate immunity. Contrib Microbiol 2008; 15: 78-100.
9. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD et al. The cellular inflammatory response in human spinal cords after injury. Brain 2006; 129: 3249-3269.
10. Beril GH, Solaroglu I, Okutan O, Cimen B, Kaptanoglu E, Palaoglu S. Metoprolol treatment decreases tissue myeloperoxidase activity after spinal cord injury in rats. J Clin Neurosci 2007; 14: 138-142.
11. Lee BH, Lee KH, Kim UJ, Yoon DH, Sohn JH, Choi SS et al. Injury in the spinal cord may produce cell death in the brain. Brain Res 2004; 1020: 37-44.
12. Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M et al. Role of neutrophils in spinal cord injury in the rat. Neuroscience 1997; 79: 1177-1182.
13. Basso DM, Beattie MS, Bresnahan JC, Anderson DK, Faden AI, Gruner JA et al. MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Neurotrauma 1996; 13: 343-359.
14. Fitch MT, Silver J. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol 2008; 209: 294-301.
15. Bao F, Chen Y, Dekaban GA, Weaver LC. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J Neurochem 2004; 88: 1335-1344.
16. Anderson AJ, Robert S, Huang W, Young W, Cotman CW. Activation of complement pathways after contusion-induced spinal cord injury. J Neurotrauma 2004; 21: 1831-1846.
17. Kaczorowski SL, Schiding JK, Toth CA, Kochanek PM. Effect of soluble complement receptor-1 on neutrophil accumulation aftertraumatic brain injury in rats. J Cereb Blood Flow Metab 1995; 15: 860-864.
18. Von Dobschuetz E, Bleiziffer O, Pahernik S, Dellian M, Hoffmann T, Messmer K. Soluble complement receptor 1 preserves endothelial barrier function and microcirculation in postischemic pancreatitis in the rat. Am J Physiol Gastrointest Liver Physiol 2004; 286: 791-796.
19. Li JS, Jaggers J, Anderson PA. The use of TP10, soluble complement receptor 1, in cardiopulmonary bypass. Expert Rev Cardiovasc Ther 2006; 4: 649-654.